https://cd4receptor.com/index.....php/decellularized-p
Of these, 60 (79% 95% CI ± 9%) had been visible on CT scan. As a result of the understanding curve of the method, the exposure enhanced in the last 75% of patients (86% visibility) compared to the first 25% of customers with 58% exposure. Regarding security associated with the BioXmark® marker, all visible markers after CT purchase remained detectable during the last CBCT without displacement. In 15/20 (75%) of the clients, three or more markers were
Like
Comment
Share
